Pavmed INC. (PAVM) — 8-K Filings

All 8-K filings from Pavmed INC.. Browse 35 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (35)

PAVmed Inc. Files 8-K: Financials & Reg FD Update — Mar 30, 2026 Risk: medium
PAVmed Inc. filed an 8-K on March 30, 2026, reporting on its Results of Operations and Financial Condition, and making Regulation FD disclosures. The filing inc
8-K Filing — Dec 30, 2025
8-K Filing — Dec 5, 2025
PAVmed Inc. Files 8-K on Financials — Nov 13, 2025 Risk: low
PAVmed Inc. filed an 8-K on November 13, 2025, reporting on its results of operations and financial condition. The filing also includes Regulation FD disclosure
PAVmed Inc. Files 8-K Report — Sep 11, 2025 Risk: low
On September 11, 2025, PAVmed Inc. filed an 8-K report detailing "Other Events" and "Financial Statements and Exhibits." The filing does not contain specific fi
PAVmed Inc. Files 8-K on Financials — Aug 14, 2025 Risk: low
PAVmed Inc. filed an 8-K on August 14, 2025, reporting on its results of operations and financial condition. The filing also includes Regulation FD disclosures
PAVmed Inc. Relocates Principal Executive Offices — Jul 30, 2025 Risk: low
PAVmed Inc. filed an 8-K on July 30, 2025, reporting an event that occurred on July 29, 2025. The filing indicates a change in the company's principal executive
PAVmed Inc. Files Material Definitive Agreement 8-K — Jun 24, 2025 Risk: medium
On June 23, 2025, PAVmed Inc. filed an 8-K report detailing a material definitive agreement. The filing also includes financial statements and exhibits. The com
PAVmed Inc. Files 8-K on Corporate Governance and Compensation — Jun 18, 2025 Risk: medium
PAVmed Inc. filed an 8-K on June 18, 2025, reporting on the departure of directors or certain officers, the election of directors, the appointment of certain of
PAVmed Inc. Files 8-K on Financials — May 15, 2025 Risk: low
PAVmed Inc. filed an 8-K on May 15, 2025, reporting on its results of operations and financial condition. The filing also includes Regulation FD disclosures and
PAVmed Inc. Appoints BDO USA, LLP as New Auditor — Apr 25, 2025 Risk: low
On April 23, 2025, PAVmed Inc. filed an 8-K report detailing changes in its certifying accountant. The company has appointed BDO USA, LLP as its new independent
PAVmed Inc. Files 8-K for Material Agreement — Apr 17, 2025 Risk: medium
On April 17, 2025, PAVmed Inc. filed an 8-K report detailing a material definitive agreement and financial statements. The company, incorporated in Delaware wit
PAVmed Inc. Files 8-K Report — Apr 11, 2025 Risk: low
PAVmed Inc. filed an 8-K report on April 11, 2025, to disclose information regarding other events and financial statements. The filing does not contain specific
PAVmed Inc. Files 8-K on Financials — Mar 25, 2025 Risk: low
On March 25, 2025, PAVmed Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, along with Regula
PAVmed Inc. Files 8-K Report — Mar 10, 2025 Risk: low
On March 5, 2025, PAVmed Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updates or d
PAVmed Inc. Reports Unregistered Equity Sales — Feb 21, 2025 Risk: medium
On February 18, 2025, PAVmed Inc. filed an 8-K report detailing unregistered sales of equity securities. The filing indicates the issuance of Series Z Warrants
PAVmed Inc. Files 8-K Report — Feb 18, 2025 Risk: low
PAVmed Inc. filed an 8-K report on February 18, 2025, detailing events that occurred on February 14, 2025. The filing includes information on "Other Events" and
PAVmed Inc. Files 8-K on Delisting Concerns — Jan 24, 2025 Risk: high
PAVmed Inc. filed an 8-K on January 23, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule. The filing also covers unregistere
PAVmed Inc. Files 8-K: Delisting Notice, Equity Sales, Bylaw Changes — Jan 21, 2025 Risk: high
PAVmed Inc. filed an 8-K on January 21, 2025, reporting a notice of delisting or failure to satisfy continued listing rules, unregistered sales of equity securi
PAVmed Inc. Files 8-K with Corporate Updates — Jan 15, 2025 Risk: low
On January 15, 2025, PAVmed Inc. filed an 8-K report detailing several key events. The company announced amendments to its Articles of Incorporation and Bylaws,
PAVmed Inc. Enters Material Definitive Agreement — Nov 29, 2024 Risk: medium
On November 22, 2024, PAVmed Inc. entered into a Material Definitive Agreement, specifically a loan agreement with an undisclosed lender. This agreement creates
PAVmed Inc. Files 8-K on Equity Sales and Security Holder Rights — Nov 21, 2024 Risk: medium
On November 15, 2024, PAVmed Inc. entered into a material definitive agreement related to unregistered sales of equity securities. This filing also addresses ma
PAVmed Inc. Appoints New CMO, Completes Acquisition — Sep 16, 2024 Risk: medium
On September 10, 2024, PAVmed Inc. announced the departure of its Chief Medical Officer, Dr. Brian Smith, and the appointment of Dr. Jessica Chen as the new Chi
PAVmed Inc. Files 8-K on Financials — Aug 13, 2024 Risk: low
On August 13, 2024, PAVmed Inc. filed an 8-K report detailing its financial condition and results of operations. The filing includes financial statements and ex
PAVmed Inc. Files 8-K on Security Holder Votes and Financials — Jun 20, 2024 Risk: low
On June 20, 2024, PAVmed Inc. filed an 8-K report detailing the submission of matters to a vote of security holders and financial statements. The filing include
PAVmed Inc. Files 8-K on Financials and Operations — May 14, 2024 Risk: medium
PAVmed Inc. filed an 8-K on May 14, 2024, reporting on its results of operations and financial condition, as well as providing Regulation FD disclosures and fin
PAVmed Inc. Files 8-K on Security Holder Rights — May 7, 2024 Risk: medium
On May 1, 2024, PAVmed Inc. entered into a material definitive agreement related to its security holders. The company, incorporated in Delaware with its princip
PAVmed Inc. Files 8-K Report — May 1, 2024 Risk: low
On April 30, 2024, PAVmed Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specific fi
PAVmed Inc. Files 8-K for Material Definitive Agreement — Apr 26, 2024 Risk: medium
On April 25, 2024, PAVmed Inc. entered into a material definitive agreement. The filing also includes financial statements and exhibits related to this agreemen
PAVmed Inc. Files 8-K: Material Definitive Agreement — Mar 14, 2024 Risk: medium
On March 12, 2024, PAVmed Inc. entered into a Material Definitive Agreement, the specifics of which are detailed in the filing. This event also constitutes a Ma
PAVmed Inc. Files 8-K Regarding Delisting Concerns — Mar 8, 2024 Risk: high
PAVmed Inc. filed an 8-K on March 7, 2024, to report a notice of delisting or failure to satisfy a continued listing rule. The company, formerly known as PAXmed
PAVmed Reports Asset Action & Security Holder Rights Modification — Feb 16, 2024 Risk: medium
PAVmed Inc. filed an 8-K on February 16, 2024, reporting events from February 15, 2024, under Item 2.01 (Completion of Acquisition or Disposition of Assets), It
PAVmed 8-K: Common Stock & Series Z Warrants Registered — Feb 9, 2024 Risk: low
PAVmed Inc. filed an 8-K on February 9, 2024, indicating an 'Other Events' disclosure. This filing primarily updates the company's registration statement to inc
PAVmed 8-K: Series Z Warrants Event Reported Jan 26 — Jan 30, 2024
PAVmed Inc. filed an 8-K on January 30, 2024, reporting an event on January 26, 2024, related to its Series Z Warrants to Purchase Common Stock. This filing ind
PAVmed Issues Series Z Warrants to Purchase Common Stock — Jan 8, 2024
PAVmed Inc. filed an 8-K on January 8, 2024, reporting an event that occurred on January 5, 2024. This filing indicates that the company issued Series Z Warrant

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX